BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20049800)

  • 1. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.
    Juliano RL; Alam R; Dixit V; Kang HM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):324-35. PubMed ID: 20049800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
    Torchilin VP
    Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular delivery of nanoparticles with CPPs.
    Sawant R; Torchilin V
    Methods Mol Biol; 2011; 683():431-51. PubMed ID: 21053148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR; Gibbons J; Verma AK; Kanwar RK
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic applications of cell-penetrating peptides.
    Johnson RM; Harrison SD; Maclean D
    Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tatp-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):816-20. PubMed ID: 17635155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular delivery of nanoparticles via the HIV-1 tat peptide.
    Berry CC
    Nanomedicine (Lond); 2008 Jun; 3(3):357-65. PubMed ID: 18510430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of cell-penetrating peptides for cargo delivery.
    Pooga M; Langel U
    Methods Mol Biol; 2005; 298():77-89. PubMed ID: 16044541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology platforms and physiological challenges for cancer therapeutics.
    Kim KY
    Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for respiratory diseases.
    Swai H; Semete B; Kalombo L; Chelule P; Kisich K; Sievers B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):255-63. PubMed ID: 20049795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-mimetic nanocarriers formed by a dipalmitoylated cell-penetrating peptide.
    Keller S; Sauer I; Strauss H; Gast K; Dathe M; Bienert M
    Angew Chem Int Ed Engl; 2005 Aug; 44(33):5252-5. PubMed ID: 16035010
    [No Abstract]   [Full Text] [Related]  

  • 18. Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.
    Pangburn TO; Petersen MA; Waybrant B; Adil MM; Kokkoli E
    J Biomech Eng; 2009 Jul; 131(7):074005. PubMed ID: 19655996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
    Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
    Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.
    Yadav SC; Kumari A; Yadav R
    Peptides; 2011 Jan; 32(1):173-87. PubMed ID: 20934475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.